Tag: Spruce Biosciences

Spruce Biosciences has filed a notice of an exempt offering of securities to raise $53,615,720.00 in New Equity Investment.

Spruce Biosciences has filed a notice of an exempt offering of securities to raise $53,615,720.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Spruce Biosciences is raising $53,615,720.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Samir Gharib played a…

Read More Read More